Price P, Cuzner M L
J Neurol Sci. 1979 Jul;42(2):251-9. doi: 10.1016/0022-510x(79)90056-x.
Levels of the proteinase inhibitors alpha 2-macroglobulin (alpha 2-m) and alpha 1-antitrypsin (alpha 1-at), and total protein, IgG and transferrin were measured in cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS) and other neurological diseases. All groups except that termed "meningitis" had similar alpha 2-m levels, but alpha 1-at and transferrin were significantly depressed in MS. Total protein levels were normal and IgG levels were elevated in MS. Serum levels of alpha 1-at were normal so the decreases observed in the CSF in MS were not due to impaired systemic production. In view of previous reports that proteinase activity is high in MS plaques and CSF, the inhibitory capacity of alpha 2-m and alpha 1-at in CSF was measured. As any decreases in inhibitory capacity noted in MS were slight, they could only be important in the local environment of a plaque where enzyme levels may be critically high.
对患有多发性硬化症(MS)和其他神经系统疾病的患者的脑脊液(CSF)中的蛋白酶抑制剂α2-巨球蛋白(α2-m)和α1-抗胰蛋白酶(α1-at)以及总蛋白、免疫球蛋白G(IgG)和转铁蛋白水平进行了测量。除了称为“脑膜炎”的组外,所有组的α2-m水平相似,但MS患者的α1-at和转铁蛋白水平显著降低。MS患者的总蛋白水平正常,IgG水平升高。血清α1-at水平正常,因此在MS患者脑脊液中观察到的降低并非由于全身产生受损。鉴于先前有报道称MS斑块和脑脊液中的蛋白酶活性较高,因此对脑脊液中α2-m和α1-at的抑制能力进行了测量。由于在MS中观察到的抑制能力的任何降低都很轻微,它们可能仅在酶水平可能极高的斑块局部环境中才重要。